News

Federal Trade Comission FTC Sign logo

The state legislature is mulling over the passage of two bills: one that would eliminate Ballad’s status as a protected monopoly, and another that would remove the Certificate of Need, a barrier that forces healthcare entities to submit expansion proposals to regulators for approval. The issue, the FTC says, is related to timing. 

liver cancer

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.

cybersecurity

Is the edge with the cybercriminals looking for weak points in firewalls? Or the security professionals trying to stop the bad guys from finding any? 

cannabis weed marijuana heart health doctor cardiologist

The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.

Steve MacMillan Hologic

The Marlborough, Massachusetts-based breast imaging vendor expects its sale to TPG and Blackstone to officially close on April 7. 

mammography mammogram breast imaging

“Radiology practices may wish to consider these findings when presenting patients with an option to pay for AI interpretation,” experts write in JACR

Leaders at the hospital have equipped the radiology department’s MRI scanner with a new AI software that essentially fills in the blanks between image slices with synthetic images.

Medicare Money

CMS officially announced the move on April 6, with it applying to the Wasteful and Inappropriate Service Reduction (WISeR) Model. 

AI model spots missed breast cancers on MRI

Re-evaluation by the second look algorithm could result in a cancer diagnosis up to one year earlier, especially for high risk disease.

The pharmacy chain is accused of charging insurance more for generic drugs than uninsured customers of its Prescription Saving Club.

The Abbott Esprit BTK everolimus-eluting biosorbable scaffold system for below the knee peripheral artery disease on display at TCT 2024. Photo by Dave FornellTCTn 2024 DF

Late-breaking data from the LIFE-BTK clinical trial showed that the Esprit BTK bioresorbable scaffold system offered better two-year outcomes than balloon angioplasty in severe peripheral artery disease (PAD) below the knee.

Thumbnail

Palliative care is a recommended part of heart failure management in the U.S., but consultation rates remain low. The trend appears to impact Black patients more than other races and ethnicities. 

Around the web

The state legislature is mulling over the passage of two bills: one that would eliminate Ballad’s status as a protected monopoly, and another that would remove the Certificate of Need, a barrier that forces healthcare entities to submit expansion proposals to regulators for approval. The issue, the FTC says, is related to timing.